Agios blood cancer drug lead jumps ship to Aprea Therapeutics

Agios blood cancer drug lead jumps ship to Aprea Therapeutics

Source: 
Fierce Biotech
snippet: 

Swedish p53 cancer biotech Aprea Therapeutics has nabbed former Agios senior medical director Eyal Attar as its senior vice president and chief medical officer.